Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Movement Disorder Neurology

Deep Brain Stimulation for MDS

At a Glance

Deep brain stimulation can substantially reduce the jerks of myoclonus-dystonia syndrome and may improve dystonia when medicines are not enough, but it is not a cure. Target choice, surgical risks, programming, and psychiatric monitoring require an experienced team.

For some people with Myoclonus-Dystonia Syndrome (MDS), standard medications may not provide enough relief from the sudden jerks and twisting postures that interfere with daily life. When symptoms remain severe despite treatment, a surgical option called Deep Brain Stimulation (DBS) may be considered [1][2].

What is Deep Brain Stimulation?

DBS is often described as a “brain pacemaker.” It involves a neurosurgeon placing thin wires (electrodes) into specific areas of the brain that control movement [3]. These wires are connected to a small device implanted under the skin of the chest, which sends electrical pulses to the brain to help regulate abnormal signals [3].

How Effective is DBS for MDS?

Research shows that DBS can be highly effective for treating the motor symptoms of MDS, often providing substantial improvements when medications fail [3][4].

  • Myoclonus Relief: In a review of 71 patients, the quick “lightning” jerks improved by an average of nearly 80% [3]. Over 94% of patients in these cohorts saw their jerk frequency cut by at least half [3].
  • Dystonia and Disability: The slower twisting movements and the overall disability caused by the condition also show significant, long-term improvement in many cases [4][5].
  • Important Context: These figures come from small, selected, largely observational cohorts. Individual responses vary, and DBS is a management tool, not a “cure.”

Choosing the Right Target

The “target” is the specific spot in the brain where the electrodes are placed. The choice of target is a specialist decision that depends on your dominant symptoms, age, and center experience:

  • GPi (Internal Globus Pallidus): This is the most common target and is often preferred if dystonia (twisting) is a major concern or if symptoms are progressive [4][3]. It is associated with fewer stimulation-induced side effects [3].
  • Vim (Ventral Intermediate Nucleus): This target is very effective at stopping myoclonus (jerks) [6]. However, a reported concern is that in some patients who receive Vim stimulation, dystonia continues to worsen later, occasionally requiring a target revision [6][7].

Important Surgical and Hardware Risks

DBS carries major physical and practical risks that require careful informed consent:

  • Surgical Risks: Hemorrhage (bleeding in the brain), stroke, infection, and seizures.
  • Hardware and Follow-up: The possibility of lead or hardware failure, the need for future surgeries for battery replacement, and ongoing programming visits to manage stimulation-related speech, balance, or cognitive effects.

The Invisible Risks: Psychiatric Nuances

Because MDS already involves psychiatric symptoms, the pre-surgical evaluation is more intense than for other conditions [1][8].

A neuropsychological evaluation is usually required or strongly expected before surgery [1][8]. This is because DBS can occasionally “unmask” or worsen psychiatric symptoms, even while it successfully fixes the movement problems [2].

  • Reported Changes: While most patients stay stable or even feel better emotionally after surgery, there are rare reports of increased OCD, aggression, depression, or apathy following DBS [2][9].
  • Complexity of Symptoms: In some cases, psychiatric worsening may require treatment even if the stimulation is changed or stopped, suggesting that the brain’s adjustment to surgery requires expert psychiatric management [2].

Building the Right Team

Success with DBS requires an experienced, multidisciplinary team at a specialized movement disorder center [1]. This team should include a functional neurosurgeon, a movement disorder neurologist, and a neuropsychologist/psychiatrist to balance the dramatic motor benefits with your overall mental well-being [8][4][10].

Common questions in this guide

Can deep brain stimulation help with myoclonus-dystonia syndrome?
DBS can substantially reduce sudden jerks and may improve twisting movements and disability when medicines have not provided enough relief. Studies report large average improvements, but responses vary and DBS manages symptoms rather than curing MDS.
Which brain target, GPi or Vim, is usually considered for MDS?
The GPi is commonly selected when dystonia or progressive symptoms are prominent and may have fewer stimulation-related side effects. The Vim can be very effective for myoclonus, but dystonia may continue to worsen in some patients, so the target depends on symptoms, age, and the experience of the treatment center.
What are the risks of DBS for myoclonus-dystonia syndrome?
Risks include bleeding in the brain, stroke, infection, seizures, lead or device failure, and future surgery to replace the battery. Ongoing programming can also cause speech, balance, or thinking effects, and psychiatric symptoms may rarely worsen.
Why is a psychological evaluation needed before DBS?
A neuropsychological evaluation checks thinking, mood, and existing psychiatric symptoms before surgery. DBS can occasionally uncover or worsen obsessive-compulsive symptoms, aggression, depression, or apathy, so mental health monitoring and treatment are part of planning.
What should I expect after DBS surgery for MDS?
After surgery, the stimulation settings need programming and adjustment, often over multiple clinic visits. Follow-up may continue long term to manage symptom response, device issues, battery needs, and possible speech, balance, cognitive, or psychiatric effects.
What kind of medical team should perform DBS for MDS?
DBS is best planned and followed by an experienced multidisciplinary team that includes a functional neurosurgeon, a movement-disorder neurologist, and a neuropsychology or psychiatry specialist. This team can balance movement benefits with cognitive and emotional well-being.

Get notified when new evidence is published on Myoclonus-dystonia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    Approach to Myoclonus Dystonia Syndrome: A European Reference Network Survey.

    Vanegas MI, Marcé-Grau A, Cazurro-Gutiérrez A, et al.

    Movement disorders clinical practice 2025; (12(7)):957-968 doi:10.1002/mdc3.70028.

    PMID: 40088059
  2. 2

    Psychiatric and Behavioral Complications of GPi DBS in an Adolescent with Myoclonus Dystonia.

    Kriegel G, Stuckey MI

    Case reports in psychiatry 2019; (2019()):1947962 doi:10.1155/2019/1947962.

    PMID: 31275687
  3. 3

    Deep brain stimulation for myoclonus dystonia syndrome: a meta-analysis with individual patient data.

    Wang X, Yu X

    Neurosurgical review 2021; (44(1)):451-462 doi:10.1007/s10143-019-01233-x.

    PMID: 31900736
  4. 4

    Long-term GPi-DBS improves motor features in myoclonus-dystonia and enhances social adjustment.

    Kosutzka Z, Tisch S, Bonnet C, et al.

    Movement disorders : official journal of the Movement Disorder Society 2019; (34(1)):87-94 doi:10.1002/mds.27474.

    PMID: 30302819
  5. 5

    Long-term effects of pallidal and thalamic deep brain stimulation in myoclonus dystonia.

    Krause P, Koch K, Gruber D, et al.

    European journal of neurology 2021; (28(5)):1566-1573 doi:10.1111/ene.14737.

    PMID: 33452690
  6. 6

    Thalamus Stimulation for Myoclonus Dystonia Syndrome: Five Cases and Long-Term Follow-up.

    Zhang YQ, Wang JW, Wang YP, et al.

    World neurosurgery 2019; (122()):e933-e939 doi:10.1016/j.wneu.2018.10.177.

    PMID: 30419400
  7. 7

    Deep brain stimulation for myoclonus-dystonia syndrome with double mutations in DYT1 and DYT11.

    Wang JW, Li JP, Wang YP, et al.

    Scientific reports 2017; (7()):41042 doi:10.1038/srep41042.

    PMID: 28102337
  8. 8

    Bilateral pallidal deep brain stimulation in myoclonus-dystonia: our experience in three cases and their follow-up.

    Fernández-Pajarín G, Sesar A, Relova JL, et al.

    Acta neurochirurgica 2016; (158(10)):2023-8 doi:10.1007/s00701-016-2904-3.

    PMID: 27531176
  9. 9

    Progression of neuropsychiatric and cognitive features due to exons 2 to 5 deletion in the epsilon-sarcoglycan gene: a case report.

    Multani N, Moro E, Lang A, et al.

    Neurocase 2016; (22(2)):215-9 doi:10.1080/13554794.2015.1120312.

    PMID: 26652670
  10. 10

    Deep Brain Stimulation in Children and Adolescents with ε-Sarcoglycan Myoclonus Dystonia Causes a Sustained Improvement in Motor Functionality and Quality of Life.

    Salazar-Villacorta A, Cazurro-Gutiérrez A, Dougherty-de Miguel L, et al.

    Movement disorders : official journal of the Movement Disorder Society 2025; (40(10)):2234-2242 doi:10.1002/mds.30309.

    PMID: 40878948

This page explains deep brain stimulation for MDS for informational purposes only and does not constitute medical advice. Your movement-disorder neurologist, neurosurgeon, and mental health specialists can help determine whether DBS is appropriate for you or your child.